In vitro activity of a novel antifungal compound, MYC-053, against clinically significant antifungal-resistant strains of Candida glabrata, Candida auris, Cryptococcus neoformans, and Pneumocystis spp.
G. Tetz, M. Collins, D. Vikina, V. Tetz
This study evaluates the antifungal activity of MYC-053 against resistant fungal strains and shows its effectiveness against biofilms and lack of toxicity.
bioRxiv · Sep 6, 2018Microbiology